Metastatic Soft Tissue Sarcoma Completed Phase 1 / 2 Trials for Conatumumab (DB11646)

Also known as: Metastatic Soft-tissue Sarcoma / Metastatic Soft-Tissue Sarcomas

IndicationStatusPhase
DBCOND0055864 (Metastatic Soft Tissue Sarcoma)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00626704Phase 1b/2 Study of AMG 655 With Doxorubicin for the First-Line Treatment of Unresectable Soft Tissue SarcomaTreatment